NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ: 089140)
South Korea
· Delayed Price · Currency is KRW
3,640.00
+95.00 (2.68%)
Nov 15, 2024, 9:00 AM KST
NEXTURNBIOSCIENCE Revenue
NEXTURNBIOSCIENCE had revenue of 7.70B KRW in the quarter ending June 30, 2024, a decrease of -19.45%. This brings the company's revenue in the last twelve months to 36.22B, down -1.08% year-over-year. In the year 2023, NEXTURNBIOSCIENCE had annual revenue of 41.26B with 75.84% growth.
Revenue (ttm)
36.22B
Revenue Growth
-1.08%
P/S Ratio
0.98
Revenue / Employee
624.47M
Employees
58
Market Cap
40.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 41.26B | 17.79B | 75.84% |
Dec 31, 2022 | 23.46B | 6.49B | 38.24% |
Dec 31, 2021 | 16.97B | 7.29B | 75.24% |
Dec 31, 2020 | 9.69B | -15.43B | -61.43% |
Dec 31, 2010 | 25.11B | 13.24B | 111.45% |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Dec 31, 2006 | Pro | Pro | Pro |
Dec 31, 2005 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition